Financial Information
- İntema
- Eczacıbaşı Pharmaceutical and Industrial Investment Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Investment Holding Co.
- Financial Information
- Announcements and Presentations
- Corporate Governance
- General Assembly
- Investor's Calendar
- Contact Us
- Eczacıbaşı Group Annual Report
Financial Highlights
| SUMMARIZED FINANCIAL DATA (Thousand TL) | 2018/12 | 2017/12 | ||
| Revenue | 692,094 | 597,909 | ||
| Gross Profit | 244,402 | 234,433 | ||
| Operating Profit | 208,363 | 129,059 | ||
| Depreciation and Amortisation | 10,343 | 10,333 | ||
| EBITDA | 218,706 | 139,392 | ||
| Net Income | 240,119 | 146,095 | ||
| 2018/12 | 2017/12 | |||
| Total Assets | 4,456,472 | 3,831,375 | ||
| Total Shareholder's Equity | 3,997,844 | 3,480,655 | ||
| Total Current Assets | 912,383 | 741,324 | ||
| Total Current Liabilities | 241,737 | 210,146 | ||
| Capital Expenditures | 16,945 | 7,937 | ||
| Liquidity Ratios (%) | 2018/12 | 2017/12 | ||
| - Current Ratio | 3.77 | 3.53 | ||
| - Liquidity Ratio | 3.41 | 3.18 | ||
| The Ratios Related to Financial Structure (%) | 2018/12 | 2017/12 | ||
| - Total Liabilities / Total Assets | 0.10 | 0.09 | ||
| - Total Shareholders' Equity / Total Assets | 0.90 | 0.91 | ||
| - Total Shareholders' Equity / Total Liabilities | 8.72 | 9.92 | ||
| Profitability Ratios (%) | 2018/12 | 2017/12 | ||
| - Net Income / Total Shareholders' Equity | 0.06 | 0.04 | ||
| - Net Income / Total Assets | 0.05 | 0.04 | ||
| - Net Income / Revenue | 0.35 | 0.24 | ||